SCHEMBL29015609

SCHEMBL29015609

CC(C)c1c(-c2cc[c]cc2)c(C(C)C)c(C2CCCCC2)c(C(C)C)c1C1CCCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28420979 0.84 POLB (0.36) —
SCHEMBL30576990 0.81 POLB (0.36) —
SCHEMBL27007938 0.75 HPGD (0.33) —
SCHEMBL30788667 0.71 RXRA (0.40) —
SCHEMBL29644614 0.70 PTPN1 (0.38) —
SCHEMBL29233400 0.68 PDCD1 (0.38) —
Phosphine SCHEMBL1505614 0.68 POLB (0.34) —
SCHEMBL28703141 0.66 ROCK2 (0.38) —
SCHEMBL30357793 0.65 PTPN1 (0.34) —
SCHEMBL6096638 0.65 NOTUM (0.46) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116947903-A Inhibitors of complement factors and uses thereof 安尼艾克松股份有限公司 2023-10-27 — — CN disclosed
CN-116261564-A Inhibitors of complement factors and uses thereof 安尼艾克松股份有限公司 2023-06-13 — — CN disclosed
Send feedback